Circulating malondialdehyde modified LDL is a biochemical risk marker for coronary artery disease

被引:45
作者
Amaki, T
Suzuki, T
Nakamura, F
Hayashi, D
Imai, Y
Morita, H
Fukino, K
Nojiri, T
Kitano, S
Hibi, N
Yamazaki, T
Nagai, R
机构
[1] Univ Tokyo, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan
[2] SRL Inc, Tokyo, Japan
关键词
D O I
10.1136/hrt.2003.018226
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
[No abstract available]
引用
收藏
页码:1211 / 1213
页数:3
相关论文
共 5 条
[1]
MALONDIALDEHYDE ALTERATION OF LOW-DENSITY LIPOPROTEINS LEADS TO CHOLESTERYL ESTER ACCUMULATION IN HUMAN MONOCYTE-MACROPHAGES [J].
FOGELMAN, AM ;
SHECHTER, I ;
SEAGER, J ;
HOKOM, M ;
CHILD, JS ;
EDWARDS, PA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (04) :2214-2218
[2]
MALONDIALDEHYDE-ALTERED PROTEIN OCCURS IN ATHEROMA OF WATANABE HERITABLE HYPERLIPIDEMIC RABBITS [J].
HABERLAND, ME ;
FONG, D ;
CHENG, L .
SCIENCE, 1988, 241 (4862) :215-218
[3]
DISTRIBUTION OF IMMUNOREACTIVE MALONDIALDEHYDE-MODIFIED LOW-DENSITY-LIPOPROTEIN IN HUMAN SERUM [J].
KOTANI, K ;
MAEKAWA, M ;
KANNO, T ;
KONDO, A ;
TODA, N ;
MANABE, M .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1994, 1215 (1-2) :121-125
[4]
THE PATHOGENESIS OF ATHEROSCLEROSIS - A PERSPECTIVE FOR THE 1990S [J].
ROSS, R .
NATURE, 1993, 362 (6423) :801-809
[5]
STEINBERG D, 1989, NEW ENGL J MED, V320, P915